Treatment of patients with immunodeficiency: Medication, gene therapy, and transplantation
Open Access
- 9 November 2020
- journal article
- review article
- Published by Elsevier in Jornal de Pediatria
- Vol. 97 (Suppl 1) , S17-S23
Abstract
No abstract availableKeywords
Funding Information
- National Council for Scientific and Technological Development
- State of São Paulo Research Foundation
- Jeffrey Modell Foundation
This publication has 38 references indexed in Scilit:
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich SyndromeScience, 2013
- Efficacy of Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2010
- Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficienciesClinical Immunology, 2010
- Antimicrobial prophylaxis for primary immunodeficienciesCurrent Opinion in Allergy and Clinical Immunology, 2009
- Immunodeficiency and infections in ataxia-telangiectasiaThe Journal of Pediatrics, 2004
- The X-Linked Hyper-IgM SyndromeMedicine, 2003
- High Dose Intravenous Immunoglobulin in Atopic Dermatitis and Hyper-IgE SyndromeAnnals of Allergy, Asthma & Immunology, 1998
- HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASEThe Lancet, 1987
- IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1968
- BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROMEThe Lancet, 1968